EcoDrugPlus

Histone Deacetylase 3

Ensembl ID : ENSPKIG00000020703
Gene Symbol: HDAC3
4 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSPKIG00000018857
Gene Symbol: HDAC4
1 Cross references
263 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSPKIG00000014049
Gene Symbol: LOC111842922
3 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSPKIG00000020952
Gene Symbol: HDAC5
1 Cross references
196 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSPKIG00000024072
Gene Symbol: HDAC6
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSPKIG00000015425
Gene Symbol: HDAC7
2 Cross references
189 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSPKIG00000019027
Gene Symbol: HDAC7
3 Cross references
195 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSPKIG00000019978
Gene Symbol: HDAC8
3 Cross references
205 Possible Orthologues:

Histone-Lysine N-Methyltransferase Ezh2

Ensembl ID : ENSPKIG00000001533
Gene Symbol: LOC111834007
3 Cross references
236 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSPKIG00000003896
Gene Symbol: HCN4
4 Cross references
285 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSPKIG00000019431
Gene Symbol: HCN4
4 Cross references
285 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSPKIG00000015988
Gene Symbol: HCRTR2
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).